In last years annual report they said they were working on 4 prototypes. In the 2023 half year they said:
PolyNovo has expanded its approachto hernia and is developing targetedsolutions to a range of herniarepair options from simple inguinalto ventral hernia and complexabdominal wall reconstruction.
and
Plastics and ReconstructiveDevice ProductsPolyNovo previously announced thatit has taken the breast developmentprogram in-house. We envisage thisprogram will leverage the experienceand processes developed for the herniadevices. The hernia product developmentmodels serve as effective building blocksfor other tissue reinforcement productsin breast, orthopaedics, and otherapplications. We anticipate thatmanufacturing processes, technologyand equipment will be shared acrossa range of new products.
Given its a building block for a number of new products I think it would be fairly high priority.
- Forums
- ASX - By Stock
- PNV
- The Clinicians Speak
The Clinicians Speak, page-550
-
-
- There are more pages in this discussion • 484 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.61 |
Change
0.090(3.57%) |
Mkt cap ! $1.801B |
Open | High | Low | Value | Volume |
$2.59 | $2.66 | $2.58 | $3.183M | 1.217M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19229 | $2.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.62 | 3084 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 19229 | 2.610 |
2 | 1339 | 2.600 |
3 | 13532 | 2.590 |
2 | 7355 | 2.580 |
1 | 1945 | 2.570 |
Price($) | Vol. | No. |
---|---|---|
2.620 | 3084 | 2 |
2.630 | 3333 | 2 |
2.640 | 13410 | 5 |
2.650 | 133891 | 6 |
2.660 | 32074 | 7 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |